As coro­n­avirus out­break reach­es 'tip­ping point,' GSK lends ad­ju­vant tech to Chi­nese part­ner armed with pre­clin­i­cal vac­cine

As the coro­n­avirus orig­i­nat­ing out of Wuhan spreads to South Ko­rea, Italy and Iran, stok­ing al­ready in­tense fears of a pan­dem­ic, Glax­o­SmithK­line has found an­oth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.